The Journal of Pediatrics
Volume 154, Issue 1 , Pages 20-23.e1 , January 2009

Smoking and Metabolic Control in Adolescents with Type 1 Diabetes

  • Sabine E. Hofer, MD

      Affiliations

    • Department of Pediatrics, Medical University of Innsbruck, Innsbruck, Austria
    • Corresponding Author InformationReprint requests: Dr. Sabine Hofer, Medical University of Innsbruck, Department of Pediatrics, Anichstrasse 35, A-6020 Innsbruck, Austria
    • ,
  • Joachim Rosenbauer, MD, PhD

      Affiliations

    • Institute of Biometrics and Epidemiology, German Diabetes Center at Heinrich Heine University of Düsseldorf, Düsseldorf, Germany
    • ,
  • Juergen Grulich-Henn, MD

      Affiliations

    • Department of Pediatrics, Medical University of Heidelberg, Heidelberg, Germany
    • ,
  • Andrea Naeke, MD

      Affiliations

    • Department of Pediatrics, University of Dresden, Dresden, Germany
    • ,
  • Elke Fröhlich-Reiterer, MD

      Affiliations

    • Department of Pediatrics, Medical University of Graz, Graz, Austria
    • ,
  • Reinhard W. Holl, MD, PhD

      Affiliations

    • Institute of Epidemiology, University of Ulm, Ulm, Germany
    • ,
  • DPV-Wiss. Study Group

Received 26 November 2007 ,Revised 21 May 2008 ,Accepted 24 July 2008.

References 

  1. Haire-Joshu D, Glasgow RE, Tibbs TL. Smoking and diabetes. Diabetes Care. 1999;22:1887–1898
  2. Celermajer DDS, Adams MR, Clarkson P, Robinson J, McCredie R, Donald A, et al. Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. N Engl J Med. 1999;334:150–151
  3. Houston TK, Person SD, Pletcher MJ, Liu K, Iribarren C, Kiefe CI. Active and passive smoking and development of glucose intolerance among young adults in a prospective cohort: CARDIA study. BMJ. 2006;332:1064–1067
  4. Nilsson PM, Gudbjornsdottir S, Eliasson B, Cederholm J. Smoking is associated with increased HbA1c values and microalbuminuria in patients with diabetes-data from the National Diabetes Register in Sweden. Diabetes Metab. 2004;30:261–268
  5. Busch P, Hammes HP, Kerner W, Kern W, Dapp A, Grabert M, et al. Rauchen als Risikofaktor für mikroangiopathische Veränderungen bei erwachsenen Patienten mit Typ 1 Diabetes: eine multizentrische Feldstudie. Diabetologie und Stoffwechsel 1. 2006;5:305–310
  6. Morgado PB, Chen HC, Patel V, Herbert L, Kohner EM. The acute effect of smoking on retinal blood flow in subjects with and without diabetes. Ophthalmology. 1994;101:1220–1226
  7. Schwab K, Doerfer J, Hallermann K, Krebs A, Schrob E, Krebs K, et al. Marked smoking-associated increase of cardiovascular risk in childhood type 1 diabetes. Int J Adolescent Med Health. 2008;20:287–294
  8. Holl RW, Grabert M, Heinze E, Debatin KM. Objective assessment of smoking habits by urinary cotinine measurement in adolescents and young adults with type 1 diabetes. Diabetes Care. 1998;21:787–791
  9. Ford ES, Newman J. Smoking and diabetes mellitus (Findings from 1988 Behavioural Risk Factor Surveillance System). Diabetes Care. 1991;14:871–874
  10. Tyc VL, Throckmorton-Belzer L. Smoking rates and the state of smoking interventions for children and adolescents with chronic illness. Pediatrics. 2006;118:471–487
  11. Holl RW, Grabert M. DPV—an electronic patient record. International Diabetes Monitor Mai. 2000;
  12. Hecker W, Grabert M, Holl RW. The German Paediatric Diabetology Group: quality of paediatric IDDM care in Germany: a multicentre analysis. J Pediatr Endocrinol Metab. 1999;12:31–38
  13. Grabert M, Schweiggert F, Holl RW. A framework for diabetes documentation and quality management in Germany: 10 years of experience with DPV. Comput Methods Programs Biomed. 2002;69:115–121
  14. Holl RW, Grabert M. The quality circle: how to improve the outcome of paediatric diabetes care. Horm Res. 2003;57(S1):105–109
  15. Schütt M, Kern W, Krause U, Busch P, Dapp A, Grziwotz R, et al. Is the frequency of self blood glucose measurements related to long-term metabolic control? (Multicenter analysis including 24.500 patients from 191 centers in Germany and Austria). Exp Clin Endocrinol Diabetes. 2006;114:384–388
  16. Schwab K, Doerfer J, Hecker W, Grulich-Henn J, Wiemann D, Kordonouri O, et al. Spectrum and prevalence of atherogenic risk factors in 27 358 children, adolescents and young adults with type 1 diabetes. Diabetes Care. 2006;29:218–225
  17. American Academy of Pediatrics. National Cholesterol Education Program: report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics. 1992;89:525–584
  18. Kromeyer-Hauschild K, Wabitsch M, Kunze D, Geller F, Geiss HC, Hesse V, et al. Percentile für den Body-mass-Index für das Kindes- und Jugendalter unter Heranziehung verschiedener deutscher Stichproben. Monatschrift Kinderheilkunde. 2001;149:807–818
  19. Mensink G, Burger M, Beitz R, Henschel Y, Hintzpeter B. Beiträge zur Gesundheitsberichterstattung des Bundes. In:  Lange R,  Ziese T editor. Ernährungsverhalten in Deutschland. Berlin: MuK (Medien und Kommunikation); 2002;p. 1331–1333
  20. Cole TJ, Green PJ. Smoothing reference centile curves: the LMS method and penalized likelihood. Stat Med. 1992;11:1305–1319
  21. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents: the fourth report on the diagnosis, evaluation and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114:555–576
  22. Lambert T, Thamm M. Tabak-, Alkohol-und Drogenkonsum von Jugendlichen in Deutschland (Ergebnisse des Kinder- und Jugendgesundheitssurveys (KiGGS)). Bundesgesundheitsblatt- Gesundheitsforschung-Gesundheitsschutz. 2007;50:600–608
  23. WHO-HBSC Survey 1998. www.hbsc.orgAccessed September 1, 2008
  24. Ismail A, Wallymahmed M, Gill G, MacFarlanet I. Failure to reduce nicotine addiction in young adults with diabetes. Diabetic Medicine. 2000;17:330–332
  25. Brink SJ. Complications of pediatric and adolescent type 1 diabetes mellitus. Current Diabetic Rep. 2001;1:47–55
  26. Diabetes Control and Complications Trial (DCCT). Epidemiology of Diabetes Intervention and Complications (EDIC) Research Group: beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT). J Pediatr. 2001;139:804–812
  27. Raile K, Galler A, Hofer S, Herbst A, Dunstheimer D, Busch P, et al. Diabetic nephropathy in 27 805 children, adolescents, and adults with type 1 diabetes. Diabetes Care. 2007;30:1–7
  28. Hammes HP, Lemmen KD, Jochmann C, Wiedemann P. Diabetic retinopathy and maculopathy. Deutsche Medizinische Wochenschrift. 2006;131:1173–1175
  29. Chiodera P, Volpi R, Capretti L, Speroni G, Necchi-Ghiri S, Caffari G, et al. Abnormal effect of cigarette smoking on pituitary hormone secretions in insulin-dependent diabetes mellitus. Clin Endocrinol. 1997;46:351–357
  30. Maahs DM, Wadwa RP, McFann K, Nadeau K, Williams MR, Eckel RH, et al. Longitudinal Lipid Screening and Use of Lipid Lowering Medications in Pediatric Type 1 Diabetes. J Pediatr. 2007;150:146–150

 The DPV initiative is financially supported by the German Ministry of Health, the German Diabetes Foundation, the German Diabetes Association, the National Action Forum against Diabetes mellitus (NAFDM), the Dr. Bürger-Büsing Foundation, the German Medical Association (BÄK), and Novo Nordisk Germany. The authors declare no conflicts of interest.

PII: S0022-3476(08)00634-3

doi: 10.1016/j.jpeds.2008.07.052

The Journal of Pediatrics
Volume 154, Issue 1 , Pages 20-23.e1 , January 2009

Article Tools

* Image Usage & Resolution